One paper has listed the various types of management of care that have been used for various types of<unk> . These are similar to management programs for other types of cardiomyopathies which include the use of ACE inhibitors, beta blockers and aspirin therapy to relieve the pressure on the heart, surgical options such as the installation of pacemaker is also an option for those thought to be at a high risk of arrhythmia problems. In severe cases, where<unk>  has led to heart failure, with resulting surgical treatment including a heart valve operation, or a heart transplant. Prognosis Due to<unk>  being a relatively new disease, its impact on human life expectancy is not very well understood. In a 2005 study that documented the long-term follow-up of 34 patients with<unk> , 35% had died at the age of 42 +/- 40 months, with a further 12% having to undergo a heart transplant due to heart failure. However, this study was based upon symptomatic patients referred to a tertiary-care center, and so were suffering from more severe forms of<unk>  than might be found typically in the population. Sedaghat-Hamedani et al. also showed the clinical course of symptomatic LVNC can be severe. In this study cardiovascular events were significantly more frequent in LVNC patients compared with an age-matched group of patients with non-ischaemic dilated cardiomyopathy (DCM). As<unk>  is a genetic disease, immediate family members are being tested as a precaution, which is turning up more supposedly healthy people with<unk>  who are asymptomatic. The long-term prognosis for these people is currently unknown.
Noncompaction cardiomyopathy
Hypertrophic cardiomyopathy
Amyloid cardiomyopathy
Restrictive cardiomyopathy
Arrhythmogenic cardiomyopathy
Ischemic cardiomyopathy
Dilated cardiomyopathy
Alcoholic cardiomyopathy